Stock screenerAll disclosures →
EDGAR →
ARQT
Conviction 71HealthcareScan · Tue, Sep 8, 2026ARQT$24.36+1.90%
ResistanceSupportVol 14Insider sellCongress buyCongress sell2
3
2
Vol MA14 1.99M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
Price24.36
Change+1.90%
Gap+3.58%
Rel volume3.71×
Avg volume1.82M
Avg $ vol45.4M
SMA 2025.02
SMA 5026.32
SMA 20025.59
Price vs 50-7.46%
Price vs 200-4.83%
MA stackmixed
50/200 cross—
Supertrenddown · 26.42
RSI (14)43
MACD hist-0.07
MACD cross—
Stoch %K / %D29 / 19
ADX (14)18
+DI / −DI22 / 23
RSI divergence—
MACD divergenceBullish
ATR %+4.08%
ADR %3.66%
52w high31.20
52w low16.73
From 52w high-21.94%
Above 52w low+45.58%
New 52w highNo
SqueezeOff
Bollinger width15.67%
%B0.33
Donchian pos28.77%
Donchian high27.19
Donchian low23.21
AVWAP (52w high)25.29
vs AVWAP high-3.68%
AVWAP (52w low)24.93
vs AVWAP low-2.29%
OBV trendFlat
Chaikin MF (20)-0.16
Today vs 20d3.71×
Avg vol (14d)1.99M
Avg vol (20d)1.82M
Avg $ vol (20d)45.4M
Market cap3.06B
RS 3m (vs SPY)+8.15%
RS 6m (vs SPY)-14.96%
RS line new highNo
Trend template4/8
Technical rank29.0
1 week+1.61%
1 month-3.70%
3 months+13.07%
6 months-1.87%
1 year+42.01%
YTD-16.02%
P/E-189.66
P/B13.88
P/S8.14
P/FCF-485.06
EPS-0.1300
Div yield—
ROE-7.32%
ROA-3.30%
Debt/Eq0.49
Current2.92
EV/EBITDA—
Gross margin—
Net margin-4.29%
Rev growth91.34%
EPS growth88.47%
Price target36.57
Target upside50.15%
Analyst ratingBuy
Institutional112.34%
Ent. value3.14B
Revenue129.86M
Net income15.01M
Gross profit—
Free cash flow-6.31M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out125.08M
Employees354
ListedFri, Jan 31, 2020
Free float109.34M
Float %89.3%
Short interest14.72M
Days to cover8.0d
Short volume66.7%
Squeeze score85 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.11 vs $0.09
Last surprise+22.2% beat
Setup gradeB
Conviction71 / 100
Pattern quality—
Tech rank29.0 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance29.11
Support23.99
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Recent news
- Arcutis Biotherapeutics (NASDAQ:ARQT) Delivers High Growth with Improving FundamentalsChartMill · Mon, Sep 7, 2026
- Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600Yahoo Finance · Fri, Sep 4, 2026
- Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Yahoo Finance · Fri, Sep 4, 2026
- (ARQT) as a Liquidity Pulse for Institutional Tacticsnews.stocktradersdaily.com · Fri, Sep 4, 2026
Congress activity
Disclosed STOCK Act trades in ARQT · 1 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
 Gilbert Cisneros house · CA · traded 2026-05-29 | Buy | $1K–$15K | 2026-05-29 | 2026-06-05 |
Insider activity
SEC Form 4 transactions in ARQT · 3 buys · 7 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Curran Terrie Director · Common Stock · 2026-08-27 | Sell | 11.15K | $279K | 2026-08-27 | 2026-08-28 |
Curran Terrie Director · Common Stock · 2026-08-27 | Exercise | 11.15K | $84K | 2026-08-27 | 2026-08-28 |
Curran Terrie Director · Common Stock · 2026-08-27 | Exercise | 27.05K | $233K | 2026-08-27 | 2026-08-28 |
Curran Terrie Director · Common Stock · 2026-08-27 | Sell | 27.05K | $677K | 2026-08-27 | 2026-08-28 |
Curran Terrie Director · Stock Option (right to buy) · 2026-08-27 | Exercise | 11.15K | — | 2026-08-27 | 2026-08-28 |
Curran Terrie Director · Stock Option (right to buy) · 2026-08-27 | Exercise | 27.05K | — | 2026-08-27 | 2026-08-28 |
Curran Terrie Director · Common Stock · 2026-08-20 | Exercise | 1.07K | $8K | 2026-08-20 | 2026-08-24 |
Curran Terrie Director · Common Stock · 2026-08-20 | Sell | 1.07K | $28K | 2026-08-20 | 2026-08-24 |
Curran Terrie Director · Stock Option (right to buy) · 2026-08-20 | Exercise | 1.07K | — | 2026-08-20 | 2026-08-24 |
Burnett Patrick See Remarks · Common Stock · 2026-08-19 | Sell | 1.7K | $46K | 2026-08-19 | 2026-08-21 |
SEC filings
EDGAR filings in ARQT · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.